forty-five patients with acute myelogenous leukaemia ( aml ) received induction chemotherapy with either a conventional dose of cytarabine and daunorubicin ( 27 patients ) or a low dose of cytarabine ( 18 patients ) .
C0023467
acute myelogenous leukaemia
C0011015
daunorubicin